sb 203580 has been researched along with octacalcium phosphate in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (octacalcium phosphate) | Trials (octacalcium phosphate) | Recent Studies (post-2010) (octacalcium phosphate) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 321 | 5 | 148 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ea, HK; Lioté, F; Rey, C; Uzan, B | 1 |
| Anada, T; Ishiko-Uzuka, R; Nishikawa, R; Suzuki, O | 1 |
2 other study(ies) available for sb 203580 and octacalcium phosphate
| Article | Year |
|---|---|
Octacalcium phosphate crystals directly stimulate expression of inducible nitric oxide synthase through p38 and JNK mitogen-activated protein kinases in articular chondrocytes.
Topics: Animals; Calcium Phosphates; Cartilage, Articular; Cattle; Cells, Cultured; Chondrocytes; Crystallization; Enzyme Induction; Flavonoids; Imidazoles; Interleukin-1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 9; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Organ Culture Techniques; p38 Mitogen-Activated Protein Kinases; Protein Biosynthesis; Pyridines; RNA, Messenger; Transcription, Genetic | 2005 |
Osteoblastic differentiation of stromal ST-2 cells from octacalcium phosphate exposure via p38 signaling pathway.
Topics: Alkaline Phosphatase; Androstadienes; Animals; Calcium Phosphates; Cell Differentiation; Cell Line; Cell Proliferation; Flavonoids; Imidazoles; Mice; Molecular Structure; Osteoblasts; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; Stromal Cells; Wortmannin | 2014 |